China Pharma Holdings (CPHI) Operating Income (QoQ) (2010 - 2026)
Powered by 
Analysis
China Pharma Holdings (CPHI) Operating Income (QoQ) (2010 - 2026) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Johnson & Johnson | 663.08 Bn | 642.33 Bn | 17.26 Bn |
| 2 | AbbVie | 453.04 Bn | 446.51 Bn | 12.70 Bn |
| 3 | Merck | 370.87 Bn | 363.78 Bn | 12.21 Bn |
| 4 | Novartis Ag | 305.29 Bn | 298.00 Bn | 11.24 Bn |
| 5 | Pfizer | 162.10 Bn | 150.70 Bn | 10.94 Bn |
| 6 | Sanofi | 53.95 Bn | 46.98 Bn | 10.79 Bn |
| 7 | Revolution Medicines | 45.00 Bn | 45.00 Bn | - |
| 8 | Incyte | 25.47 Bn | 20.94 Bn | 1.57 Bn |
| 9 | United Therapeutics | 20.81 Bn | 18.15 Bn | 683.80 Mn |
| 10 | China Pharma Holdings | 33.23 Mn | 32.92 Mn | 83,566.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -28.16% |
| Mar 31, 2026 | 6.91% |
| Dec 31, 2025 | -91.07% |
| Sep 30, 2025 | 3.68% |
| Jun 30, 2025 | 14.04% |
| Mar 31, 2025 | 36.57% |
| Dec 31, 2024 | -10.21% |
| Sep 30, 2024 | 22.01% |
| Jun 30, 2024 | -51.90% |
| Mar 31, 2024 | 22.66% |
| Dec 31, 2023 | -66.00% |
| Sep 30, 2023 | -56.37% |
| Jun 30, 2023 | -14.80% |
| Mar 31, 2023 | 66.00% |
| Dec 31, 2022 | -69.75% |
| Sep 30, 2022 | 11.66% |
| Jun 30, 2022 | 14.49% |
| Mar 31, 2022 | -40.55% |
| Dec 31, 2021 | 14.92% |
| Sep 30, 2021 | -1.26% |